GlassScriptPhysician profile
Norberto S Hernandez
NPI 1255946935
$2,380.08
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $736 · 2022: $1,534 · 2023: $32.40 · 2024: $77.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $575.02 | 2021-2024 | |
| Novo Nordisk INC | $256.56 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $189.82 | 2022-2024 | Wainua |
| Lilly USA, LLC | $184.95 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $179.80 | 2022 | |
| Acadia Pharmaceuticals INC | $156.29 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.78 | 2022 | |
| Amgen INC. | $132.63 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $85.92 | 2021-2022 | |
| Biogen, INC. | $83.21 | 2021 | |
| Merck Sharp & Dohme LLC | $82.19 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.18 | 2022 | |
| Jazz Pharmaceuticals INC. | $36.61 | 2022 | |
| Genentech USA, INC. | $35.88 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.14 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $24.24 | 2021 | |
| Grt US Holding, INC. | $24.07 | 2021 | |
| Currax Pharmaceuticals LLC | $16.67 | 2021 | |
| Neurocrine Biosciences, INC. | $15.01 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.21 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.02 | 2021 | |
| Organon LLC | $13.85 | 2022 | |
| Allergan, INC. | $13.00 | 2021 | |
| Almatica Pharma LLC | $12.03 | 2021 | |
| Althera Pharmaceuticals LLC | $11.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norberto Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.